The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with platinum-resistant epithelial ovarian cancer.
 
Judith Michels
No Relationships to Disclose
 
François Ghiringhelli
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Roche; Sanofi; SERVIER
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Roche; SERVIER
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; Novartis; Pfizer; Roche
 
Caroline Brard
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; Novartis; Roche/Genentech; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
Anne Floquet
Consulting or Advisory Role - AstraZeneca; CLOVIS ONCOLOGY; GlaxoSmithKline; MSD Oncology; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Roche; Tesaro
 
Lauriane Eberst
No Relationships to Disclose
 
Rastilav Bahleda
No Relationships to Disclose
 
Catherine Genestie
No Relationships to Disclose
 
Corinne Balleyguier
Travel, Accommodations, Expenses - Bracco Diagnostics; GE Healthcare; Guerbet; Siemens Healthineers
 
Sophie Broutin
No Relationships to Disclose
 
Patricia Pautier
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro
 
Emeline Colomba
No Relationships to Disclose
 
Fanny Pommeret
No Relationships to Disclose
 
Christophe Massard
No Relationships to Disclose
 
Aurelien Marabelle
Stock and Other Ownership Interests - Centessa Pharmaceuticals; Centessa Pharmaceuticals (Inst); HiFiBiO Therapeutics; PEGASCY; PEGASCY (Inst); Shattuck Labs
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Oncovir
Consulting or Advisory Role - AstraZeneca; Centessa Pharmaceuticals; Eisai; HiFiBiO Therapeutics; ImCheck therapeutics; Innate Pharma; Lytix Biopharma; MedinCell; MSD; OSE Immunotherapeutics; Pierre Fabre; Redx Pharma; Roche; SERVIER; Sotio
Speakers' Bureau - BMS
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - monoclonal antibodies against CD81 (Stanford University)
Travel, Accommodations, Expenses - AstraZeneca; MSD
 
Alexandra Leary
Honoraria - AstraZeneca; Clovis Oncology
Consulting or Advisory Role - Ability Pharma (Inst); AstraZeneca (Inst); BioCad; Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); Tesaro (Inst); zentalis
Research Funding - GamaMabs Pharma (Inst); Inivata (Inst); Merus (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro